7,842 press releases indexed under healthcare.
Collaboration will bring the needs of underserved communities into the open ecosystem shaping agentic AI Summary Gates Foundation becomes the first philanthropic organization to join the Agentic AI Foundation (AAIF) and bring its global perspective across health, education, agriculture...
Reconocido a nivel nacional en todas las especialidades pediátricas, con dos de ellas situadas entre las cinco primeras Clasificaciones principales: El mejor hospital infantil del norte de California Clasificado como el segundo mejor hospital infantil de California Entre los cinco mejores...
Nationally recognized in all pediatric specialties, with two specialties ranked in the top 5 Key rankings: Best Children's Hospital in Northern California Ranked No. 2 Children's Hospital in California Top 5 nationally in two specialties: Neonatology and Nephrology Top 10 nationally in...
Heart Center ranked Number One in the nation for 10th consecutive year; Diabetes & Endocrinology also earned country's top ranking HOUSTON, Sept. 15, 2026 /PRNewswire/ -- Texas Children's has again been named to the U.S. News & World Report Best Children's Hospitals Honor Roll. The...
This edition commemorates two decades of guiding families to high-quality pediatric care, recognizing 90 top children's hospitals across 11 pediatric specialties. 90 children's hospitals recognized across 34 states and Washington, D.C., for exceptional pediatric care. 11 pediatric medical...
Centers for Medicare & Medicaid Services began its Medicare GLP-1 Bridge on July 1, 2026, giving eligible Medicare Part D beneficiaries access to certain GLP-1 drugs, and its BALANCE model — Better Approaches to Lifestyle, Nutrition for Comprehensive health — pairs access to GLP-1...
(PR-inside.com) ● Dr. Frederick D. Sancilio to present "Reimagining Psychedelic Therapeutics for Daily Outpatient Use: Advancing Low-Dose Psilocin Beyond the Hallucinogenic Paradigm" on Wednesday, September 16 ● Presentation covers Phase 1a first-in-human results for Conjugated Psilocin™ (L-130), including oral bioavailability, dose consistency and the absence of hallucinogenic effects at low doses ● Lobe to exhibit throughout the summit, September 15-17, alongside senior discovery, clinical and business development leaders from major pharmaceutical companies VANCOUVER, BC / ACCESS Newswire / September 14, 2026 / Lobe Sciences Ltd. (CSE:LOBE)(OTCQB:LOBEF)(FWB:LOBE.F) ("Lobe" or the "Company"), a clinical-stage biopharmaceutical company developing drug candidates for diseases with limited t
● Dr. Frederick D. Sancilio to present "Reimagining Psychedelic Therapeutics for Daily Outpatient Use: Advancing Low-Dose Psilocin Beyond the Hallucinogenic Paradigm" on Wednesday, September 16 ● Presentation covers Phase 1a first-in-human results for Conjugated Psilocin™ (L-130), including oral bioavailability, dose consistency and the absence of hallucinogenic effects at low doses ● Lobe to exhibit throughout the summit, September 15-17, alongside senior discovery, clinical and business development leaders from major pharmaceutical companies
Shanghai, China--(Newsfile Corp. - September 14, 2026) - Frost & Sullivan has conducted comprehensive research on the global gut microbiota industry and published the "White Book on the Current Landscape and Future Trends of the Gut Microbiota Industry". The white paper provides a comprehensive overview of gut microbiota, exploring its relationship with health and disease, the current landscape of gut microbiota drug development, market insights, and future trends. The White Book begins by...
Shanghai, China--(Newsfile Corp. - September 14, 2026) - Frost & Sullivan has conducted comprehensive research on China's radiofrequency-based medical aesthetic devices industry and published the "Blue Book on the Current Status and Future Trends of the Chinese Radiofrequency-Based Medical Aesthetic Devices Industry" in September 2026. This report focuses on the application of radiofrequency technology in the medical aesthetics sector. Taking this as a starting point, it provides an in-depth...
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / September 14, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Fractyl Health, Inc. (NASDAQ:GUTS) securities. If you suffered a loss on your Fractyl Health, Inc. investment and would like to explore a potential recovery under the federal securities laws, Learn about Fractyl Health, Inc. Class Action or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)363-7500 to speak to our team of experienced shareholder advocates. THE LAWSUIT: A class action securities lawsuit was filed ..